archive: Re: SETI Market Timing

Re: SETI Market Timing

Ray Shank ( )
Sat, 31 Oct 1998 07:33:15 -0600

So Jon,

Are you telling us this because your 66 low level satellites are going to
cause us trouble with our radio telescopes? Are your satellites going to
cause interference on our protected frequencies?

I guess I don't see any SETI relevance in your little article. I suggest
that you are simply spamming our list.

At 11:38 AM 10/31/98 -0500, you wrote:
>October 29, 1998
>Market Timing
>Table of Contents
>1. Market Commentary
>2. USDI - a player in the IRIDIUM Satellite project
>3. NLAB update
>4. Departments
>As predicted in our last issue the US equity markets have
>stabilized and begun to head higher again.
>Asian markets have had a nice rebound and some currencies
>have begun to strengthen against the US dollar. Hong Kong
>continues to show some weakness, but these problems can
>probably be traced back to the actions of the Chinese
>government in Beijing.
>During the last week European markets have also begun to
>move higher once again. Against this backdrop and more
>importantly to our subscribers, there is a groundswell
>of interest and commentary developing in and about the
>"small cap" sector of the market. The Russell 2000 small
>cap index has moved from a low of 303.87 in the first week
>of October/98 to close on October 23/98 at 367.05. This
>is an increase of over 17% in 2 weeks.
>We believe the market is entering a phase where interest
>will begin to increase in this long neglected sector of
>the market. There are excellent investment grade and
>speculative opportunities in this area, which have long
>been overlooked by the institutional money managers with
>their fixation on the Dow 30 stocks. The DOW is now
>beginning to look, if not a little tired, at least fully
>valued. The fund managers are now going to have to go
>to work and find new areas in which to deploy their
>client's money.
>Leverage is a bad word on Wall Street these days and without
>leverage these managers are stuck with relatively low returns
>in the bond and money markets (under 5% on 30 year US treasury
>bills). It is our feeling this will result in more money flowing
>into the smaller cap sector of the market - and remember - with
>the huge amount of money now in mutual funds and the market in
>general, it only takes a relatively small reallocation of assets
>by market participants, to have a substantial impact on the
>price of these smaller company's shares.
>We are profiling a new company in this issue of MT:
>US Digital Communications Inc.
>Symbol: USDI Trades: OTC BB
>USDI is a proxy for one of the biggest events in the
>evolution of wirelesses communications the IRIDIUM
>Global Communications System. USDI in conjunction
>with its subsidiaries SKYSITE (,
>INSAT and PROJECT 77 (, is a
>supplier of both the Motorola and Kyocera telephones
>and pagers and a resellers of air time for the IRIDIUM
>network. As such, expect to see their revenues and
>profits grow in lock step with the growth of the overall
>satellite network.
>The IRIDIUM satellite phone system consists of 66 low-level
>satellites, which completely cover every point of the planet.
>This $5 billion dollar investment allows any point or
>individual on earth to access telephone, data transfer
>or paging service.
>The 19 members of this consortium, which has been
>spearheaded by Motorola, include some of the largest
>telecom companies in the world, as well as a number of
>very large Middle Eastern, Asian and South American
>private investment companies. The financial commitment
>is very large and IRIDIUM ( will
>go into service November 1, 1998. The "start" date for
>IRIDIUM service is one of the reasons that we are bringing
>this company to your attention now.
>As you can see if you look at a chart of the stock
>( the USDI's share price peaked
>at $7.00 in early July of this year, in what we believe
>was anticipation of the original service commencement date
>of September 23, 1998. When it became obvious this date
>was going to be pushed back to November 1, momentum was
>lost by the stock. It then bottomed out on October 8 at
>$2.30. In the last week it has moved back to close on Friday
>(Oct 23) at $3.93 up 7/8s of a point or 28.5% for the day
>on 366,200 shares traded! See the October 23 USDI News
>Release at:
>The IRIDIUM name will be on a lot of peoples "radar"
>screens soon as a $100 million public relations, marketing
>and advertising program will help launch this service.
>This is definitely a "timing" and "momentum" play and
>there is no doubt that the very wealthy and smart companies
>and individuals that are part of the IRIDIUM consortium are
>going to work hard to make this THE wireless network of
>the future.
>Given the momentum that is building in the stock, USDI
>could easily see its old high of $7.00 between now and
>shortly after startup of the IRIDIUM service in the next
>week. Depending on a stable market and some positive news,
>which we fully expect, and given the sophistication of the
>underwriters and companies behind the IRIDIUM project, USDI
>prices above $10 are quite possible over the next 90 days.
>NuOncology Labs Inc. (NLAB - OTC BB) continues to make
>progress on its business plan and have announced the opening
>of their new offices, predictive oncology testing and
>research building in Houston TX. (See October 15th News
>Release at: This new
>facility is capable of performing testing to the rate of
>1000 comprehensive predictive profiles per month.
>MT heard NuOncology is planning a road show in Europe
>that will include NLAB management starting early in
>November. These "show and tell" meetings are intended
>to attract additional funding, market sponsorship as
>well as institutional and broker interest for NLAB.
>We expect soon after this trip there will be further
>word on the Arglabin/FTI issue by way of publication
>of their research in a recognized medical journal.
>In addition there will be more results coming on the
>second large sample of patients who have been undergoing
>treatment for various types of cancer with Arglabin.
>The share price has fallen on relatively small volume and
>somewhat tracks the skittish market we have had for the last
>2 months. It would not be inconceivable that this market
>rebounds right back to the $6.50 range in a day or two of
>trading - especially if there is some further news on the
>use of Arglabin as a successful cancer therapy.
>REMEMBER this is not a theoretical concept NLAB is working
>on - people ARE BEING TREATED with ARGLABIN today and their
>CANCERS ARE IN REMISSIOIN. This company has the potential
>to be a $500 million - $1 Billion cap company and we believe
>you will begin to see some recognition of this in the
>marketplace BEFORE THE END OF NOVEMBER. For a current
>quote on NLAB please go to:
>A. Stock Quotes
>B. How to Unsubscribe to MT
>C. Disclaimer
>For stock quotes on any company please go to:
>Please note, as per your request you are a subscriber
>to MT. If at any time you wish to unsubscribe please
>put 'unsubscribe' in the subject of your e-mail and return to:
>MT respects your privacy and will NEVER release your e-mail
>address to a third party for any reason.
>By being a subscriber you are acknowledging you have read
>and fully understand our disclaimer below.
>MarketTiming (hereafter called MarketTiming) is an
>independent electronic publication devoted to providing
>information and factual analysis on selected companies
>that in the opinion of MarketTiming have investment
>potential. Companies featured by MarketTiming may have
>paid MarketTiming or their affiliates the editor or the
>editor's affiliates family or agents for the dissemination
>of company information through MarketTiming. MarketTiming
>and/or its affiliates or principals may have been paid in
>cash, stock or stock options to disseminate information
>about the companies it has featured. These payments may
>have been acquired prior to the dissemination of information
>on any particular company featured by MarketTiming and stock
>positions held by MarketTiming employees, affiliates or
>principals may increase or decrease at any time. Such
>compensation received by MarketTiming or any of its employees,
>the editor or any affiliates should be viewed by readers as
>a potential conflict of interest. The principals of
>MarketTiming or its affiliates may have from time to time
>had business dealings with, or hold a substantial stock
>position in any of the companies featured. Principals,
>family or affiliates of MarketTiming may also buy hold or
>sell securities (long or short) in the companies mentioned
>at any time prior to or after a particular company has been
>featured by MarketTiming. Our purpose is to locate and
>research equity investments in micro or small capitalization
>companies that in our opinion has the potential for long-term
>appreciation. Investing in any stock must be considered
>risky, however investing in the companies MarketTiming reviews
>must be considered to be high risk and use of the information
>provided is at the investor's sole risk. Purchase of such
>high-risk securities may result in loss of some or all of
>the investor's original investment. All statements and
>expressions are the opinion of MarketTiming and/or its
>principals and affiliates and are not meant to be a
>solicitation or recommendation to buy, sell, or hold
>securities. MarketTiming is not a registered investment
>advisor or broker dealer. The information MarketTiming
>basis its reports on are generally provided by the
>company being featured or may come from sources and/or
>interviews conducted by MarketTiming. While every effort
>is made to provide true and meaningful information no
>guarantee is made by MarketTiming as to the accuracy
>of the information provided. Investors should not rely
>solely on the information contained in MarketTiming
>reports to make an investment decision. They should
>consult a registered broker or financial advisor before
>purchasing any stock. Investors should consider the
>information provided by MarketTiming a starting point
>for doing additional independent research on any of the
>featured companies. Companies featured are often at
>very early stages of development and can therefore be
>subject to business failure, which could result in the
>investor losing all his or her investment. Statements
>of fact in the MarketTiming reports are made as of the
>date stated and are subject to change without notice.
>Recipients of MarketTiming reports must assume that
>there has been a change in the affairs of companies
>profiled, from the date of the report - to the time
>it may be seen by them. Recipients should independently
>ascertain from their own investment advisors or the
>company being profiled the current accuracy of any
>statements, which may influence their investment decisions.
>Investing in micro-cap securities is highly speculative
>and carries an extremely high degree of risk. It is
>possible that an investor's investment may be lost
>or impaired due to the speculative nature of the
>companies profiled by MarketTiming. By subscribing to
>MarketTiming all subscribers acknowledge they have read
>and fully understand the above disclaimer.

Ray Shank -
Argus Observatory EM26eh
Construction Site